The angiotensin-converting enzyme (ACE) gene () insertion/deletion () polymorphism raises the possibility of personalising ACE inhibitor therapy to optimise its efficiency and reduce side effects in genetically distinct subgroups. However, the extent of its influence among these subgroups is unknown. Therefore, we extended our computational model of blood pressure regulation to investigate the effect of the polymorphism on haemodynamic parameters in humans undergoing antihypertensive therapy.
View Article and Find Full Text PDFHypertension is a multifactorial disease arising from complex pathophysiological pathways. Individual characteristics of patients result in different responses to various classes of antihypertensive medications. Therefore, evaluating the efficacy of therapy based on predictions is an important task.
View Article and Find Full Text PDFCancer treatment and pharmaceutical development require targeted treatment and less toxic therapeutic intervention to achieve real progress against this disease. In this scenario, nanomedicine emerged as a reliable tool to improve drug pharmacokinetics and to translate to the clinical biologics based on large molecules. However, the ability of our body to recognize foreign objects together with carrier transport heterogeneity derived from the combination of particle physical and chemical properties, payload and surface modification, make the designing of effective carriers very difficult.
View Article and Find Full Text PDFBioUML (https://www.biouml.org)-is a web-based integrated platform for systems biology and data analysis.
View Article and Find Full Text PDF